Comment

Chronic pancreatitis (CP) is a progressive inflammatory disease of the gland characterized with non-reversible morphologic changes, like progressive destruction of exocrine and endocrine parenchyma, as well as ductular structures, followed with fibrosis and pancreatic exocrine and endocrine function impairment. The correlation between structural and functional changes is often poor. Pancreatogenic diabetes is often recognized late in the course od the disease, often when it’s complications are already present.

Advanced stages of CP are easily diagnosed with imaging techniques, as ultrasound, computed tomography or endosonography (EUS). On the other hand, despite the significant progress in the knowledge on chronic CP pathogenesis, an early detection of the disease is rarely possible.

Pancreatic cancer (PC) accounts for 3% of all malignant neoplasms diagnosed each year in the world and is the 4th most common cause of cancer deaths. The aggressive course, late diagnosis and resistance to treatment result in 5 year survival lower than 5% and very high mortality in the 6 months period after diagnosis. At the diagnosis 80-90% patients have an advanced disease and the tumor is non-operable. Numerous studies concentrate on developing specific and sensitive diagnostic and prognostic marker of PC, but the results are unsatisfactory yet.

In this issue of „Postępy Nauk Medycznych” the important and not clearly elucidated problem of coexisting diabetes in CP and PC is being analysed in the article titled „The emergence of carbohydrate metabolism disorders in the course of pancreatic adenocarcinoma (PC) and chronic pancreatitis (CP) – assessment of insulin level and insulin resistance” by Wlodarczyk

To jest tylko fragment artykułu. Aby przeczytać całość, przejdź do Czytelni medycznej.